TrialJournal of bone and mineral metabolism2017

Visfatin is a positive predictor of bone mineral density in young survivors of acute lymphocytic leukemia.

Adriana Aparecida Siviero-Miachon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.